Prehospital blood transfusion: who benefits?
Thies K-C, Ruetzler K (2022)
The Lancet Haematology 9(4): e238-e239.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Thies, Karl-ChristianUniBi;
Ruetzler, Kurt
Erscheinungsjahr
2022
Zeitschriftentitel
The Lancet Haematology
Band
9
Ausgabe
4
Seite(n)
e238-e239
ISSN
23523026
Page URI
https://pub.uni-bielefeld.de/record/2982834
Zitieren
Thies K-C, Ruetzler K. Prehospital blood transfusion: who benefits? The Lancet Haematology. 2022;9(4):e238-e239.
Thies, K. - C., & Ruetzler, K. (2022). Prehospital blood transfusion: who benefits? The Lancet Haematology, 9(4), e238-e239. https://doi.org/10.1016/S2352-3026(22)00074-6
Thies, Karl-Christian, and Ruetzler, Kurt. 2022. “Prehospital blood transfusion: who benefits?”. The Lancet Haematology 9 (4): e238-e239.
Thies, K. - C., and Ruetzler, K. (2022). Prehospital blood transfusion: who benefits? The Lancet Haematology 9, e238-e239.
Thies, K.-C., & Ruetzler, K., 2022. Prehospital blood transfusion: who benefits? The Lancet Haematology, 9(4), p e238-e239.
K.-C. Thies and K. Ruetzler, “Prehospital blood transfusion: who benefits?”, The Lancet Haematology, vol. 9, 2022, pp. e238-e239.
Thies, K.-C., Ruetzler, K.: Prehospital blood transfusion: who benefits? The Lancet Haematology. 9, e238-e239 (2022).
Thies, Karl-Christian, and Ruetzler, Kurt. “Prehospital blood transfusion: who benefits?”. The Lancet Haematology 9.4 (2022): e238-e239.
Google Scholar